New
HealthMore in Health →
European drug panel backs four new medicines and a new form of Sanofi’s Sarclisa
The European Medicines Agency’s human medicines committee has recommended four new drugs and a subcutaneous form of Sanofi’s multiple myeloma treatment Sarclisa, setting up a new set of regulatory decisions in Europe.
Key Takeaways
- CHMP recommended four new drugs and a subcutaneous form of Sanofi’s Sarclisa.
- The decision is an important scientific milestone ahead of final European Commission action.
DE
DT Editorial AI··via endpoints.news